KR101685656B1 - 붕소를 함유하는 소분자 - Google Patents

붕소를 함유하는 소분자 Download PDF

Info

Publication number
KR101685656B1
KR101685656B1 KR1020167009966A KR20167009966A KR101685656B1 KR 101685656 B1 KR101685656 B1 KR 101685656B1 KR 1020167009966 A KR1020167009966 A KR 1020167009966A KR 20167009966 A KR20167009966 A KR 20167009966A KR 101685656 B1 KR101685656 B1 KR 101685656B1
Authority
KR
South Korea
Prior art keywords
exemplary embodiment
compound
delete delete
substituted
another exemplary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167009966A
Other languages
English (en)
Korean (ko)
Other versions
KR20160049025A (ko
Inventor
스티븐 제이. 베이커
빈센트 에스. 에르난데스
라시미 샤르마
제임스 에이. 니먼
츠토마 아카마
용-강 장
제이콥 제이. 플레트너
마이클 리차드 케빈 앨리
라제시워 싱
이 시아
후첸 조우
라힘 모하마드
엘 메흐디 케라만
샤오송 루
민 하
제임스 쥐. 필립스
Original Assignee
아나코르 파마슈티칼스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40156702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101685656(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 아나코르 파마슈티칼스 인코포레이티드 filed Critical 아나코르 파마슈티칼스 인코포레이티드
Publication of KR20160049025A publication Critical patent/KR20160049025A/ko
Application granted granted Critical
Publication of KR101685656B1 publication Critical patent/KR101685656B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020167009966A 2007-06-20 2008-06-19 붕소를 함유하는 소분자 Active KR101685656B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US94529407P 2007-06-20 2007-06-20
US60/945,294 2007-06-20
US4117808P 2008-03-31 2008-03-31
US61/041,178 2008-03-31
PCT/US2008/067550 WO2008157726A1 (en) 2007-06-20 2008-06-19 Boron-containing small molecules

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020157021997A Division KR20150100945A (ko) 2007-06-20 2008-06-19 붕소를 함유하는 소분자

Publications (2)

Publication Number Publication Date
KR20160049025A KR20160049025A (ko) 2016-05-04
KR101685656B1 true KR101685656B1 (ko) 2016-12-12

Family

ID=40156702

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020167009966A Active KR101685656B1 (ko) 2007-06-20 2008-06-19 붕소를 함유하는 소분자
KR1020107001062A Active KR101578351B1 (ko) 2007-06-20 2008-06-19 붕소를 함유하는 소분자
KR1020157021997A Abandoned KR20150100945A (ko) 2007-06-20 2008-06-19 붕소를 함유하는 소분자

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020107001062A Active KR101578351B1 (ko) 2007-06-20 2008-06-19 붕소를 함유하는 소분자
KR1020157021997A Abandoned KR20150100945A (ko) 2007-06-20 2008-06-19 붕소를 함유하는 소분자

Country Status (29)

Country Link
US (4) US7816344B2 (OSRAM)
EP (1) EP2164331B1 (OSRAM)
JP (3) JP5530923B2 (OSRAM)
KR (3) KR101685656B1 (OSRAM)
CN (2) CN104017008A (OSRAM)
AR (1) AR067105A1 (OSRAM)
AU (1) AU2008265630B2 (OSRAM)
BR (1) BRPI0813450B8 (OSRAM)
CA (1) CA2692135C (OSRAM)
CL (1) CL2008001855A1 (OSRAM)
CO (1) CO6251209A2 (OSRAM)
CR (1) CR11224A (OSRAM)
DK (1) DK2164331T3 (OSRAM)
DO (1) DOP2009000281A (OSRAM)
EA (1) EA020530B1 (OSRAM)
ES (1) ES2655299T3 (OSRAM)
IL (1) IL202379A (OSRAM)
JO (1) JO3396B1 (OSRAM)
MA (1) MA31675B1 (OSRAM)
MX (1) MX347688B (OSRAM)
MY (1) MY162692A (OSRAM)
NO (1) NO2164331T3 (OSRAM)
NZ (1) NZ582706A (OSRAM)
PE (1) PE20090840A1 (OSRAM)
SG (1) SG182219A1 (OSRAM)
TW (1) TW200911822A (OSRAM)
UY (1) UY31171A1 (OSRAM)
WO (1) WO2008157726A1 (OSRAM)
ZA (2) ZA200909003B (OSRAM)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2597982C (en) 2005-02-16 2014-07-08 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
KR20080110984A (ko) 2005-12-30 2008-12-22 아나코르 파마슈티칼스 인코포레이티드 보론함유 소분자
RS54108B1 (sr) 2006-02-16 2015-12-31 Anacor Pharmaceuticals Inc. Mali molekuli koji sadrže boron kao agensi protiv zapaljenja
JP2009536660A (ja) 2006-05-02 2009-10-15 アナコール ファーマシューティカルズ，インコーポレイテッド 加水分解耐性ホウ素含有治療剤及びその使用方法
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
EP2564857B1 (en) 2008-03-06 2017-05-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
WO2009140309A2 (en) * 2008-05-12 2009-11-19 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
EP2348863A4 (en) 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc BORN SMALL MOLECULES
WO2010028005A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010045503A1 (en) * 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
WO2010080558A1 (en) * 2008-12-17 2010-07-15 Anacor Pharmaceuticals, Inc. Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
WO2010132833A1 (en) * 2009-05-14 2010-11-18 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
KR20130031233A (ko) 2009-07-28 2013-03-28 아나코르 파마슈티칼스 인코포레이티드 삼치환된 붕소 함유 분자
WO2011019612A1 (en) 2009-08-14 2011-02-17 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011019616A1 (en) 2009-08-14 2011-02-17 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011019618A1 (en) 2009-08-14 2011-02-17 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
MX2012002031A (es) * 2009-08-19 2012-07-04 Anacor Pharmaceuticals Inc Moleculas pequeñas que contienen boro como agentes antiprotozoarios.
US20110124597A1 (en) * 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
US8979820B2 (en) 2009-10-09 2015-03-17 Cynthia S. Bailey Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes
US9346834B2 (en) 2009-10-20 2016-05-24 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011060196A1 (en) * 2009-11-11 2011-05-19 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US8716478B2 (en) 2010-01-27 2014-05-06 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
AP2012006482A0 (en) 2010-03-19 2012-10-31 Anacor Pharmacueticals Inc Boron-containing small molecules as anti-protozoalagent
CA2794684C (en) * 2010-04-07 2018-04-24 Glaxosmithkline Llc Process for preparing benzoxaboroles
KR102152901B1 (ko) * 2010-09-07 2020-09-07 아나코르 파마슈티칼스 인코포레이티드 세균 감염을 치료하기 위한 벤족사보롤 유도체
WO2013025975A1 (en) * 2011-08-17 2013-02-21 Glaxosmithkline Llc Combination treatments for hepatitis c
WO2013049424A1 (en) 2011-09-28 2013-04-04 Wisconsin Alumni Research Foundation Catalytic conversion of cellulose to fuels and chemicals using boronic acids
AR088668A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Moleculas pequeñas que contienen boro
AR088669A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
EP2793901A1 (en) 2011-12-22 2014-10-29 Micurx Pharmaceuticals, Inc. Tricyclic boron compounds for antimicrobial therapy
US20150080342A1 (en) 2012-04-14 2015-03-19 Anacor Pharmaceuticals, Inc. Benzoxaborole compounds and uses thereof
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
MX356059B (es) 2013-01-30 2018-05-11 Dow Agrosciences Llc Uso de benzoxaboroles como agentes antimicrobianos volatiles en carnes, plantas, o partes de plantas.
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
AP2015008638A0 (en) 2013-02-01 2015-08-31 Anacor Pharmaceuticals Inc Boron-containing small molecules as antiprotozoal agents
AU2014202928B1 (en) * 2013-06-05 2014-09-11 Agrofresh Inc. Compounds and compositions
KR101636431B1 (ko) * 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
PE20160752A1 (es) 2013-08-09 2016-08-17 Anacor Pharmaceuticals Inc Compuestos de benzoxaborol triciclicos y usos de los mismos
EA038093B1 (ru) * 2013-12-20 2021-07-05 Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли
BR112016018483A2 (pt) * 2014-02-17 2018-07-10 Syngenta Participations Ag benzoxaboróis ativos do ponto de vista microbicida
ES2732465T3 (es) 2014-07-01 2019-11-22 Daiichi Sankyo Co Ltd Benzoxaboroles tricíclicos como agentes antibacterianos
WO2016069955A1 (en) * 2014-10-29 2016-05-06 Wisconsin Alumni Research Foundation Boronic acid inhibitors of hiv protease
MA41495A (fr) 2015-02-12 2017-12-19 Anacor Pharmaceuticals Inc Composés benzoxaborole et leurs utilisations
BR112017021478B1 (pt) * 2015-04-09 2022-04-19 The Penn State Research Foundation Composição antifúngica sinérgica que contém benzoxaborol
WO2017024022A1 (en) * 2015-08-06 2017-02-09 The Penn State Research Foundation Benzoxaborole-containing coating resistant to cellulose-supportable fungus
CN113845536A (zh) 2016-03-02 2021-12-28 比尔及梅琳达盖茨基金会 含硼小分子
WO2017151489A1 (en) 2016-03-02 2017-09-08 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US10874679B2 (en) 2016-03-02 2020-12-29 Bill & Melinda Gates Foundation Boron-containing small molecules
EP3426029B1 (en) 2016-03-07 2023-08-30 AgroFresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
UA121354C2 (uk) 2016-05-12 2020-05-12 Анакор Фармасутікалз, Інк. Нові сполуки для лікування паразитарних захворювань
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
CN107090000B (zh) * 2017-04-27 2019-07-12 上海交通大学 一种苯并硼唑7位脂肪酸的衍生物及其制备与用途
EP3639005B1 (en) * 2017-06-13 2024-05-22 Veterinary Diagnostics Institute, Inc. Method for extracting blood samples from dried blood spots
US20190159457A1 (en) * 2017-11-30 2019-05-30 Boragen, Inc. Combinatorial Compositions of Benzoxaboroles and Biologic Agents
JP2021505660A (ja) * 2017-11-30 2021-02-18 ボラゲン，インコーポレーテッド ベンゾキサボロール化合物およびその配合物
US11236115B2 (en) 2018-08-18 2022-02-01 5Metis, Inc. Solid forms of substituted benzoxaborole and compositions thereof
WO2020051575A1 (en) * 2018-09-07 2020-03-12 Boragen, Inc. Boron containing compounds and their uses
US11058695B2 (en) * 2019-11-08 2021-07-13 Myongji University Industry And Academia Cooperation Foundation Inhibitor of carbapenem-hydrolyzing class D beta-lactamases
US20230340530A1 (en) 2020-08-31 2023-10-26 Pfizer Inc. Methods of Protecting RNA
AU2023287202A1 (en) * 2022-06-23 2024-06-06 Shanghai Micurx Pharmaceutical Co., Ltd. Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
AU2023287063A1 (en) * 2022-06-23 2024-05-30 Shanghai Micurx Pharmaceutical Co., Ltd. Prodrugs of boron compounds and their use in treating bacterial infections
US12482208B2 (en) 2023-05-30 2025-11-25 Snap Inc. Mirroring 3D assets for virtual experiences

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060234981A1 (en) 2005-02-16 2006-10-19 Anacor Pharmaceuticals Boron-containing small molecules
KR101578351B1 (ko) 2007-06-20 2015-12-17 아나코르 파마슈티칼스 인코포레이티드 붕소를 함유하는 소분자

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260336A (en) * 1939-10-16 1941-10-28 Dow Chemical Co Method of preparation of organic borates
GB1396904A (en) 1972-08-11 1975-06-11 Ici Ltd Method for the control of micro-organisms
US5962498A (en) * 1986-06-11 1999-10-05 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
US5594151A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) * 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
US5831046A (en) * 1996-08-05 1998-11-03 Prolinx, Incorporated Boronic acid-contaning nucleic acid monomers
US6306628B1 (en) * 1999-08-25 2001-10-23 Ambergen, Incorporated Methods for the detection, analysis and isolation of Nascent proteins
AU7995300A (en) * 1999-10-05 2001-05-10 Bethesda Pharmaceuticals, Inc. Dithiolane derivatives
WO2002006316A2 (en) * 2000-07-14 2002-01-24 Zycos, Inc. Alpha-msh related compounds and methods of use
US6537733B2 (en) * 2001-02-23 2003-03-25 Applied Materials, Inc. Method of depositing low dielectric constant silicon carbide layers
GB0117645D0 (en) * 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de) 2001-09-07 2003-03-27 Clariant Gmbh Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
US7217701B2 (en) * 2001-10-11 2007-05-15 Katsuhiko Mikoshiba Intracellular calcium concentration increase inhibitors
US7405304B2 (en) 2002-01-10 2008-07-29 The Penn State Research Foundation Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids
PL372246A1 (en) * 2002-05-28 2005-07-11 3-Dimensional Pharmaceuticals, Inc. Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
CN1829521B (zh) * 2003-06-16 2011-01-26 安纳考尔医药公司 耐水解的含硼治疗剂和使用方法
DK1755661T3 (da) * 2004-05-12 2014-06-16 Brigham & Womens Hospital Gelsolin til anvendelse til behandling af infektioner
KR20080110984A (ko) * 2005-12-30 2008-12-22 아나코르 파마슈티칼스 인코포레이티드 보론함유 소분자
RS54108B1 (sr) * 2006-02-16 2015-12-31 Anacor Pharmaceuticals Inc. Mali molekuli koji sadrže boron kao agensi protiv zapaljenja
WO2007146965A2 (en) 2006-06-12 2007-12-21 Anacor Pharmaceuticals, Inc. Compounds for the treatment of periodontal disease
US20070286822A1 (en) * 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
DE102006038471A1 (de) 2006-08-17 2008-04-10 Wala-Heilmittel Gmbh Platanencreme, Verfahren zu ihrer Herstellung und Verwendung
WO2009140309A2 (en) * 2008-05-12 2009-11-19 Anacor Pharmaceuticals, Inc. Boron-containing small molecules

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060234981A1 (en) 2005-02-16 2006-10-19 Anacor Pharmaceuticals Boron-containing small molecules
KR101578351B1 (ko) 2007-06-20 2015-12-17 아나코르 파마슈티칼스 인코포레이티드 붕소를 함유하는 소분자

Also Published As

Publication number Publication date
US20090227541A1 (en) 2009-09-10
EP2164331A4 (en) 2011-09-07
PE20090840A1 (es) 2009-07-08
NZ582706A (en) 2012-07-27
US10533021B2 (en) 2020-01-14
MA31675B1 (fr) 2010-09-01
MY162692A (en) 2017-07-14
DOP2009000281A (es) 2010-07-31
BRPI0813450A2 (pt) 2014-12-30
ZA200909003B (en) 2022-03-30
CN101772302A (zh) 2010-07-07
EP2164331A1 (en) 2010-03-24
CN101772302B (zh) 2014-05-07
EA020530B1 (ru) 2014-11-28
EA200901617A1 (ru) 2010-06-30
TW200911822A (en) 2009-03-16
KR20150100945A (ko) 2015-09-02
SG182219A1 (en) 2012-07-30
KR20160049025A (ko) 2016-05-04
JP5530923B2 (ja) 2014-06-25
JP2016040275A (ja) 2016-03-24
MX347688B (es) 2017-05-09
CR11224A (es) 2010-06-28
CO6251209A2 (es) 2011-02-21
IL202379A0 (en) 2010-06-30
JP2014148531A (ja) 2014-08-21
US20100292504A1 (en) 2010-11-18
AU2008265630A1 (en) 2008-12-24
BRPI0813450B8 (pt) 2021-05-25
ES2655299T3 (es) 2018-02-19
CN104017008A (zh) 2014-09-03
BRPI0813450B1 (pt) 2019-05-07
JP6570391B2 (ja) 2019-09-04
US20180016285A1 (en) 2018-01-18
JO3396B1 (ar) 2019-10-20
WO2008157726A1 (en) 2008-12-24
AU2008265630B2 (en) 2013-06-20
DK2164331T3 (da) 2018-01-29
JP2010530881A (ja) 2010-09-16
NO2164331T3 (OSRAM) 2018-04-28
US8895534B2 (en) 2014-11-25
KR20100051615A (ko) 2010-05-17
EP2164331B1 (en) 2017-11-29
AR067105A1 (es) 2009-09-30
CL2008001855A1 (es) 2009-05-29
UY31171A1 (es) 2009-04-30
US20150133402A1 (en) 2015-05-14
CA2692135A1 (en) 2008-12-24
KR101578351B1 (ko) 2015-12-17
US7816344B2 (en) 2010-10-19
ZA201104573B (en) 2014-03-26
US9796735B2 (en) 2017-10-24
CA2692135C (en) 2017-01-24
IL202379A (en) 2016-02-29

Similar Documents

Publication Publication Date Title
KR101685656B1 (ko) 붕소를 함유하는 소분자
JP6491294B2 (ja) 細菌感染治療用のベンゾオキサボロール誘導体
WO2011037731A1 (en) Boron containing small molecules
HK1141681A (en) Boron-containing small molecules
HK1141681B (en) Boron-containing small molecules
HK1247841B (en) Benzoxaborole derivatives for treating bacterial infections

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20160415

Application number text: 1020157021997

Filing date: 20150813

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160624

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20161109

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20161206

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20161207

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20190924

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20190924

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20201117

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20211118

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20221027

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee